Combining Biologic Agents in Inflammatory Bowel Disease...Maria T. Abreu

Detalles Bibliográficos
Publicado en:Gastroenterology & Hepatology pp. 549 - 552
Autor principal: Abreu, Maria T.
Formato: interview pictorial Journal Article
Publicado: Gastro-Hep Communications, Inc Oct2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139147130&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139147130
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15547914
        6N5B
      jtl: Gastroenterology & Hepatology
      issn: 15547914
      maglogo: N
    pubinfo:
      dt: Oct2019
      pid: 72163
      pub: Gastro-Hep Communications, Inc
      place: New York, New York
    artinfo:
      ui:
        139147130
        139147130
        139147130
        139147130
      ppf: 549
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Combining Biologic Agents in Inflammatory Bowel Disease...Maria T. Abreu
      aug:
        au: Abreu, Maria T.
        affil: Director, Crohn's & Colitis Center
      sug:
        subj:
          Inflammatory Bowel Diseases Drug Therapy
          Antibodies, Monoclonal Therapeutic Use
          Drug Combinations Pharmacodynamics
          Immune System Drug Effects
          Inflammatory Bowel Diseases Immunology
          Janus Kinases Antagonists and Inhibitors
          Interleukins Drug Effects
          Treatment Outcomes
          Tumor Necrosis Factor Antagonists and Inhibitors
          Antibodies, Monoclonal Pharmacodynamics
      pubtype: Academic Journal
      doctype:
        interview
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N